Since 2006, AusDiagnostics has been committed to bringing the benefits of molecular science to the world, to help enable better diagnostic decisions in human diagnostics, animal diagnostics and applied testing.

The first MT-PCR panel was introduced in 2006, and since then, through ongoing collaboration with leading clinical laboratories, research institutes and experts, we have been able to deliver beneficial solutions that add value to our customers.

Today our clinical diagnostic products are used by laboratories and hospitals around the world to detect and test for a broad range of diseases and conditions. Our multiplexing platform has also helped to abridge lengthy testing processes for our customers across their different industries.

Headquartered in Australia, AusDiagnostics prides itself in its evolution to a multi-national company with subsidiaries in New Zealand, United States and United Kingdom, and manufacturing facilities in Australia and United Kingdom. We have an ever-growing network of over 25 distributors and partners who help us drive a positive impact to customers around the globe.